AR124923A1 - RECOMBINANT MENINGOCOCCAL B VACCINE - Google Patents

RECOMBINANT MENINGOCOCCAL B VACCINE

Info

Publication number
AR124923A1
AR124923A1 ARP220100354A ARP220100354A AR124923A1 AR 124923 A1 AR124923 A1 AR 124923A1 AR P220100354 A ARP220100354 A AR P220100354A AR P220100354 A ARP220100354 A AR P220100354A AR 124923 A1 AR124923 A1 AR 124923A1
Authority
AR
Argentina
Prior art keywords
vaccine
protein
fhbp
combination
recombinant meningococcal
Prior art date
Application number
ARP220100354A
Other languages
Spanish (es)
Inventor
Nadge Arnaud-Barbe
Vinod Balhara
Raffaella Iantomasi
Marie Kazek-Duret
- Mcluskey Jacqueline Pierre
Laurence Quemeneur
Bachra Rokbi
John SHIVER
Original Assignee
Sanofi Pasteur Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sanofi Pasteur Inc filed Critical Sanofi Pasteur Inc
Publication of AR124923A1 publication Critical patent/AR124923A1/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/095—Neisseria
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/22—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Neisseriaceae (F)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55505—Inorganic adjuvants

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Epidemiology (AREA)
  • Immunology (AREA)
  • Microbiology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Mycology (AREA)
  • Genetics & Genomics (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)

Abstract

Reivindicación 1: Una composición inmunógena que comprende una combinación de antígenos del serogrupo B de Neisseria meningitidis, comprendiendo dicha combinación al menos una proteína de unión al factor H proteína A (fHBP), al menos una proteína fHBP B, al menos una proteína adhesina A de Neisseria (NadA) y al menos una vesícula de membrana externa extraída con detergente (dOMV). Reivindicación 13: Una vacuna que comprende una composición según una cualquiera de las reivindicaciones 1 a 12.Claim 1: An immunogenic composition comprising a combination of Neisseria meningitidis serogroup B antigens, said combination comprising at least one factor H binding protein A (fHBP), at least one fHBP B protein, at least one adhesin A protein (NadA) and at least one detergent-extracted outer membrane vesicle (dOMV). Claim 13: A vaccine comprising a composition according to any one of claims 1 to 12.

ARP220100354A 2021-02-19 2022-02-18 RECOMBINANT MENINGOCOCCAL B VACCINE AR124923A1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP21305211 2021-02-19

Publications (1)

Publication Number Publication Date
AR124923A1 true AR124923A1 (en) 2023-05-17

Family

ID=74867492

Family Applications (1)

Application Number Title Priority Date Filing Date
ARP220100354A AR124923A1 (en) 2021-02-19 2022-02-18 RECOMBINANT MENINGOCOCCAL B VACCINE

Country Status (1)

Country Link
AR (1) AR124923A1 (en)

Similar Documents

Publication Publication Date Title
CY1117957T1 (en) FULL OMV VACANCY AGAINST MININGOKOK
ECSP10010723A (en) MULTIVALLY NATIVE EXTERNAL MEMBRANE VESICLE VACCINE OF THE MENINGOCOCO, METHOD FOR MANUFACTURING AND USE
BR112012022688A2 (en) fusion protein, isolated outer membrane vesicle, polynucleotide, pharmaceutical composition, vaccine, method for treating or preventing neisseria infection or disease, use and method for making a fusion protein
PE20142115A1 (en) COMPOSITIONS OF NEISSERIA MENINGITIDIS AND METHODS OF THE SAME
CY1115308T1 (en) VACCINE COMPOSITIONS CONTAINING AN IMMUNE SAPONIN EXCIPIENT
CY1112105T1 (en) Immunogenic Bacterial Bladders with External Membrane Proteins
EP3058954A3 (en) Immunogenic compositions and methods
CR10123A (en) VACCINE.
RU2013133864A (en) Compositions of Meningococcal Vaccines
PE20040562A1 (en) VACCINES INVOLVING MIXTURES OF MULTIVALENT MENINGOCOCCAL STRAINS
CO2023010612A2 (en) Recombinant meningococcal b vaccine
RU2015100889A (en) Vaccines for meningococcus serogroup X
AR124923A1 (en) RECOMBINANT MENINGOCOCCAL B VACCINE
CL2023001142A1 (en) Compositions and methods for vaccination against Neisseria gonorrhoeae
RU2008144180A (en) MYCOPLASMA VACCINE AND PRRSV
BR112013010338A2 (en) composition, methods for preparing an immunogenic composition, for assisting an immune response, for eliciting an immune response against an infectious agent, for preventing and / or reducing amyloid deposition or alzheimer's disease in an individual, and for treating / reducing / ameliorating infection with an infectious agent, use of a protein, and kit
CU20200057A7 (en) VACCINE COMPOSITIONS AGAINST THE SARS-CoV-2 VIRUS BASED ON A DIMER OF THE BINDING DOMAIN TO THE RECEPTOR AND THE OUTER MEMBRANE VESICLE OF MENINGOCOCCUS B
AR123474A1 (en) VESICLES OF THE OUTER MEMBRANE
ECSP055978A (en) GANGLIOSIDE-BASED VACCINE COMPOSITIONS FOR SUBCUTANEOUS ADMINISTRATION
AR046921A1 (en) METHOD FOR THE INCORPORATION OF ANTIGENS IN EXTERNAL MEMBRANE VESICULES OF BACTERIA AND RESULTING FORMULATIONS
RU2364418C2 (en) VACCINE COMPOSITIONS CONTAINING L2 AND/OR L3 IMMUNOTYPE LIPOPOLYSACCHARIDES AND ORIGINATED FROM STRAIN NEISSERIA MENINGITIDIS IgtB-
BR112022020100A2 (en) INACTIVATED VACCINE AGAINST SARS-COV-2 VIRUS
AR126730A1 (en) VACCINE AGAINST CLOSTRIDIUM CHAUVOEI AND PRODUCTION METHOD
BR0313120A (en) bleb and de los preparations, neisserial / neisserial strain (s), immunogenic composition or vaccine, and, manufacturing processes of the neisserial bleb preparation vaccine and production of a bleb preparation
WO2005023295A3 (en) Naturally processed immunodominant peptides derived from neisseria meningitidis porin a protein and their use